Ligand validation:6I61

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6I61_GOL_A_504	44%	48%	0.157	0.885	0.9	1.09	-	-	1	0	100%	1
6I61_GOL_A_507	18%	50%	0.224	0.807	0.85	1.09	-	-	0	0	100%	1
6I61_GOL_A_503	11%	51%	0.181	0.692	0.8	1.09	-	1	0	0	100%	1
6I61_GOL_A_506	9%	55%	0.301	0.798	0.73	1.01	-	-	1	0	100%	1
6I61_GOL_A_505	6%	47%	0.453	0.887	0.92	1.12	-	1	0	0	100%	1
6I64_GOL_A_504	23%	41%	0.213	0.834	1.3	1	1	1	0	0	100%	1
2E2R_GOL_A_501	10%	84%	0.325	0.83	0.39	0.38	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.